Kineta to Participate in Upcoming Investor Conferences
SEATTLE, Aug. 31, 2023 -- Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune resistanc ...